Rapid Diagnosis of Smear-Negative Tuberculosis Using Immunology and Microbiology with Induced Sputum in HIV-Infected and Uninfected Individuals

Rationale and Objectives Blood-based studies have demonstrated the potential of immunological assays to detect tuberculosis. However lung fluid sampling may prove superior as it enables simultaneous microbiological detection of mycobacteria to be performed. Until now this has only been possible using the expensive and invasive technique of broncho-alveolar lavage. We sought to evaluate an immunoassay using non-invasive induced-sputum to diagnose active tuberculosis. Methods and Results Prospective cohort study of forty-two spontaneous sputum smear-negative or sputum non-producing adults under investigation for tuberculosis. CD4 lymphocytes specific to purified-protein-derivative of Mycobacterium tuberculosis actively synthesising interferon-gamma were measured by flow cytometry and final diagnosis compared to immunoassay using a cut-off of 0.5%. Sixteen subjects (38%) were HIV-infected (median CD4 count [range] = 332 cells/µl [103–748]). Thirty-eight (90%) were BCG-vaccinated. In 27 subjects diagnosed with active tuberculosis, the median [range] percentage of interferon-gamma synthetic CD4+ lymphocytes was 2.77% [0–23.93%] versus 0% [0–2.10%] in 15 negative for active infection (p<0.0001). Sensitivity and specificity of the immunoassay versus final diagnosis of active tuberculosis were 89% (24 of 27) and 80% (12 of 15) respectively. The 3 positive assays in the latter group occurred in subjects diagnosed with quiescent/latent tuberculosis. Assay performance was unaffected by HIV-status, BCG-vaccination or disease site. Combining this approach with traditional microbiological methods increased the diagnostic yield to 93% (25 of 27) alongside acid-fast bacilli smear and 96% (26 of 27) alongside tuberculosis culture. Conclusions These data demonstrate for the first time that a rapid immunological assay to diagnose active tuberculosis can be performed successfully in combination with microbiological methods on a single induced-sputum sample.

[1]  Charles L Daley,et al.  Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Yim,et al.  Usefulness of Whole-Blood Interferon-γ Assay and Interferon-γ Enzyme-Linked Immunospot Assay in the Diagnosis of Active Pulmonary Tuberculosis , 2007 .

[3]  Holden Maecker,et al.  Loss of Receptor on Tuberculin-Reactive T-Cells Marks Active Pulmonary Tuberculosis , 2007, PloS one.

[4]  G. Janossy,et al.  Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis , 2007, Thorax.

[5]  S. Gillespie,et al.  Biomarkers of treatment response in clinical trials of novel antituberculosis agents. , 2007, The Lancet. Infectious diseases.

[6]  Paul Bassett,et al.  Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Pai,et al.  Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research , 2007, Annals of Internal Medicine.

[8]  G. Maartens,et al.  Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. , 2007, American journal of respiratory and critical care medicine.

[9]  Federico Girosi,et al.  Reducing the global burden of tuberculosis: the contribution of improved diagnostics , 2006, Nature.

[10]  M. Raviglione XDR-TB: entering the post-antibiotic era? , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  M. Johnson,et al.  Detection of mycobacterial antigen responses in lung but not blood in HIV-tuberculosis co-infected subjects , 2006, AIDS.

[12]  J. Mora,et al.  T-cell homing specificity and plasticity: new concepts and future challenges. , 2006, Trends in immunology.

[13]  Ajit Lalvani,et al.  Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study , 2004, The Lancet.

[14]  M. Pai,et al.  Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review , 2004 .

[15]  P. Andersen,et al.  Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. , 2004, American journal of respiratory and critical care medicine.

[16]  G. Janossy,et al.  Optimal gating strategies for determining bronchoalveolar lavage CD4/CD8 lymphocyte ratios by flow cytometry. , 2004, Journal of immunological methods.

[17]  J. Deeks,et al.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.

[18]  G. Janossy,et al.  Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis. , 2003, The Journal of infectious diseases.

[19]  A. Wells,et al.  Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis , 2002, Thorax.

[20]  M. Behr,et al.  Profound T-lymphocytopenia and cryptococcemia in a human immunodeficiency virus-seronegative patient with disseminated tuberculosis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  M. Conde,et al.  Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil. , 2000, American journal of respiratory and critical care medicine.

[22]  Z. Toossi,et al.  Pulmonary Mononuclear Cell Responses to Antigens of Mycobacterium tuberculosis in Healthy Household Contacts of Patients with Active Tuberculosis and Healthy Controls from the Community1 2 , 2000, The Journal of Immunology.

[23]  R. Belshe,et al.  Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Z. Toossi,et al.  Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. , 1999, The Journal of infectious diseases.

[25]  Y. Schwarz,et al.  Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease. , 1999, Respiratory medicine.

[26]  M. Torres,et al.  Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. , 1998, The Journal of infectious diseases.

[27]  A. McMichael,et al.  Rapid Effector Function in CD8+ Memory T Cells , 1997, The Journal of experimental medicine.

[28]  P. Andersen,et al.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG , 1996, Infection and immunity.

[29]  C. Smith,et al.  The Clinical Application of a Rapid Lung-Orientated TB Immunoassay in Individuals with Possible Tuberculosis , 2007 .

[30]  J. Yim,et al.  Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. , 2007, Chest.

[31]  M. Pai,et al.  Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  P. Dewan,et al.  Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  M. Lipman,et al.  Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. , 2007, American journal of respiratory and critical care medicine.

[34]  M. Pai,et al.  Interferon-γ Release Assays: What Is Their Role in the Diagnosis of Active Tuberculosis? , 2007 .

[35]  P. Dewan,et al.  Low Sensitivity of a Whole-Blood Interferon-γ Release Assay for Detection of Active Tuberculosis , 2007 .

[36]  M. Pai,et al.  Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. , 2004, The Lancet. Infectious diseases.